Lehucher Ceyrac D, Chaspoux C, Sulimovic L, Morel P, Lefrancq H
Service Dermatologie, Hôpital Saint-Louis, Paris.
Ann Dermatol Venereol. 1998 Aug;125(8):496-9.
Acne flare-ups are frequent in the early phase of isotretinoin treatment. Severity varies from one patient to another. Clinical factors favoring a potentially severe course were assessed on the basis of 6 cases.
Six male patients, mean age 16.5 years, with inflammatory acne with a major retentional component were studied. Isotretinoin administered at a daily dose 0.5 mg/kg led to explosive development of massive nodulocystic lesions or pyogenic granulomas within two months. The lesions healed at withdrawal of isotretinoin and administration of antibiotics and antiinflammatory drugs. There was important scar sequellae.
Four concomitant factors were identified which contribute to the development of acne flare-ups: sex (male), young age, retentional form of acne and daily isotretinoin dose 0.5 mg/kg.
异维A酸治疗早期痤疮频繁发作。严重程度因人而异。基于6例病例评估了有利于潜在严重病程的临床因素。
研究了6例男性患者,平均年龄16.5岁,患有具有主要潴留成分的炎性痤疮。每日剂量0.5mg/kg的异维A酸导致在两个月内爆发性出现大量结节囊肿性病变或化脓性肉芽肿。在停用异维A酸并给予抗生素和抗炎药后病变愈合。有重要的瘢痕后遗症。
确定了四个导致痤疮发作的伴随因素:性别(男性)、年轻、潴留型痤疮和每日异维A酸剂量0.5mg/kg。